1. Home
  2. ADMA vs ALK Comparison

ADMA vs ALK Comparison

Compare ADMA & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • ALK
  • Stock Information
  • Founded
  • ADMA 2004
  • ALK 1932
  • Country
  • ADMA United States
  • ALK United States
  • Employees
  • ADMA N/A
  • ALK N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • ALK Air Freight/Delivery Services
  • Sector
  • ADMA Health Care
  • ALK Consumer Discretionary
  • Exchange
  • ADMA Nasdaq
  • ALK Nasdaq
  • Market Cap
  • ADMA 5.8B
  • ALK 6.0B
  • IPO Year
  • ADMA N/A
  • ALK N/A
  • Fundamental
  • Price
  • ADMA $19.98
  • ALK $52.03
  • Analyst Decision
  • ADMA Strong Buy
  • ALK Strong Buy
  • Analyst Count
  • ADMA 4
  • ALK 12
  • Target Price
  • ADMA $24.25
  • ALK $65.75
  • AVG Volume (30 Days)
  • ADMA 4.5M
  • ALK 3.7M
  • Earning Date
  • ADMA 05-07-2025
  • ALK 04-23-2025
  • Dividend Yield
  • ADMA N/A
  • ALK N/A
  • EPS Growth
  • ADMA N/A
  • ALK 48.41
  • EPS
  • ADMA 0.84
  • ALK 2.83
  • Revenue
  • ADMA $459,381,000.00
  • ALK $12,640,000,000.00
  • Revenue This Year
  • ADMA $18.45
  • ALK $25.70
  • Revenue Next Year
  • ADMA $26.96
  • ALK $6.09
  • P/E Ratio
  • ADMA $23.92
  • ALK $18.35
  • Revenue Growth
  • ADMA 62.23
  • ALK 20.82
  • 52 Week Low
  • ADMA $6.84
  • ALK $32.62
  • 52 Week High
  • ADMA $25.67
  • ALK $78.08
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 43.06
  • ALK 59.36
  • Support Level
  • ADMA $18.75
  • ALK $42.01
  • Resistance Level
  • ADMA $23.98
  • ALK $53.51
  • Average True Range (ATR)
  • ADMA 1.38
  • ALK 2.15
  • MACD
  • ADMA -0.34
  • ALK 1.47
  • Stochastic Oscillator
  • ADMA 17.77
  • ALK 89.19

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

Share on Social Networks: